ibopamine has been researched along with Cardiac Failure in 149 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 57 (38.26) | 18.7374 |
1990's | 86 (57.72) | 18.2507 |
2000's | 6 (4.03) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Erhardt, PW | 1 |
Petrie, CJ; van Veldhuisen, DJ; Voors, AA | 1 |
Goldberg, LI; Rajfer, SI | 3 |
Brusoni, B; Cadel, A; Ladelli, L; Mangiavacchi, M; Pezzano, A; Sala, G | 1 |
Forattini, C; Gabellini, A; Reffo, GC; Turrin, M | 1 |
Col, J; Mievis, E; Reynaert, M | 1 |
Bernardini, B; Dei Cas, L; Manca, C; Mansour, M; Vasini, G; Zonca, A | 1 |
Mengeot, P; Mirgaux, M; Piette, F | 1 |
Andrews, R; Cowley, AJ; Evans, A; Walsh, JT | 1 |
Azevedo, JE; Campos Filho, O; Cantarelli, MJ; Carvalho, AC; de Almeida, DR; Martinez Filho, EE; Smith, AC | 1 |
Girbes, AR; Lie, KI; Lieverse, AG; Meijer, S; Reitsma, WD; Smit, AJ; Van Veldhuisen, DJ; Zijlstra, JG | 2 |
Boomsma, F; Brouwer, J; Dunselman, PH; Haaksma, J; Lie, KI; Man in 't Veld, AJ; van Veldhuisen, DJ | 1 |
Arcensio, SR; Arteaga, E; Barretto, AC; Bellotti, G; da Luz, PL; Mady, C; Pileggi, F; Szambock, F | 1 |
Cas, LD; Metra, M; Missale, C; Spano, PF | 1 |
Oosterbosch, C | 1 |
Francis, GS | 1 |
Pouleur, H | 1 |
Dei Cas, L; Metra, M | 1 |
de Voogt, WG; Groeneveld, AB; Hoekstra, OS; Holman, ND; Schneider, AJ; van der Meer, J | 1 |
Brouwer, J; Dohmen, HJ; Dunselman, PH; Lie, KI; Lok, DJ; Man in 't Veld, AJ; Pasteuning, WH; Poortermans, JC; van Veldhuisen, DJ; Withagen, AJ | 1 |
Ahn, S; Benedict, CR; Donckier, J; Galanti, L; Ketelslegers, JM; Kinan, D; Konstam, MA; Melin, J; Pouleur, H; Rousseau, MF | 1 |
Lie, KI; van Zwieten, PA | 1 |
Remme, WJ | 1 |
Scheen, AJ | 1 |
Girbes, AR; Kalisvaart, CJ; Pasteuning, WH; Reitsma, WD; Smit, AJ; Tan, ET; Van Veldhuisen, DJ | 1 |
López-Sendón, JL | 1 |
Bucx, JJ; Dankbaar, H; Huizing, G; Said, SA; van Gilst, WH | 1 |
Parker, JO | 1 |
Buikema, H; de Smet, BJ; Lie, KI; Scholtens, E; van Gilst, WH; van Veldhuisen, DJ; Wesseling, H | 1 |
de Graeff, PA; Girbes, AR; Lie, KI; van den Broek, SA; van Gilst, WH; van Veldhuisen, DJ | 1 |
Burri, M; Kehtari, R; Metzger, J; Reuge, L | 1 |
Cosín Aguilar, J; Cruz Fernández, JM; de Teresa Galván, E; Ferreira Montero, IJ; López-Sendón, J; Soler Soler, J; Tamargo Menéndez, J | 1 |
Girbes, AR; Kruik, J; Lie, KI; Szabó, BM; van der Burgh, PH; van Veldhuisen, DJ | 1 |
Dei Cas, L; Metra, M; Nodari, S; Raccagni, D | 1 |
Campa, PP; Dawodu, AA; De Biase, L; Gentile, C; Lilla Della Monica, PL; Monti, F; Puddu, PE; Schiariti, M; Vaccaro, M | 1 |
Coats, AJ; Niebauer, J | 1 |
Ardia, A; Block, P; Cortina, A; Cowley, AJ; Cserhalmi, L; Follath, F; Hampton, JR; Jensen, G; Kayanakis, J; Kleber, FX; Lie, KI; Mancia, G; Skene, AM; van Veldhuisen, DJ | 1 |
Van Veldhuisen, DJ | 1 |
Andrews, R; Charlesworth, A; Cowley, AJ; Evans, A | 1 |
Massel, D | 1 |
Girbes, AR; Zijlstra, JG | 1 |
Hampton, JR | 1 |
Dohmen, HJ; Dunselman, PH; Poole-Wilson, PA | 1 |
Struthers, AD; Yee, KM | 1 |
Girbes, AR; Smit, AJ | 1 |
Feenstra, J; Grobbee, DE; Ottervanger, JP; Porsius, AJ; Stricker, BH | 1 |
Mitha, AS; Naidoo, DP; Rocke, A | 1 |
Feenstra, J; Grobbee, DE; in't Veld, BA; Stricker, BH; van der Linden, PD | 1 |
de Graeff, PA; Elferink, AJ; Lekkerkerker, JF | 1 |
Vandenbroucke, JP | 1 |
Smit, AJ | 1 |
Cobelli, F; Febo, O | 1 |
Boomsma, F; Charlesworth, A; de Kam, PJ; de Zeeuw, D; Girbes, AR; Hampton, JR; Hillege, HL; van Veldhuisen, DJ | 1 |
Charlesworth, A; Cowley, AJ; Hampton, JR; Kleber, FX; Van Veldhuisen, DJ | 1 |
Feenstra, H; Grobbee, RE; in't Veld, BA; Stricker, BH | 1 |
Poole-Wilson, PA; van Veldhuisen, DJ | 1 |
Cabell, B; Glogar, D; Kleber, FX; Sabin, GV; Thyroff-Friesinger, U | 1 |
Hayashida, W; Kawai, C; Kumada, T | 1 |
Dei Cas, L; Metra, M; Visioli, O | 1 |
Lotti, G; Musso, NR; Pouleur, H; Raigoso, J; Rousseau, MF; van Eyll, C; Van Mechelen, H | 1 |
Itoh, H; Koike, A; Nakamura, S; Sato, Y; Taniguchi, K; Tsujibayashi, T | 1 |
Astorga, MA; Ceia, F; Coelho, EM; Fonseca, C; Gil, V; Gomes, RS; Gouveia, R; Luís, AS; Mota, E; Riva, E | 1 |
Man in't Veld, AJ | 1 |
López-Sendón, J | 2 |
Pouleur, H; Raigoso, J; Rousseau, MF | 1 |
Crijns, HJ; Girbes, AR; Lie, KI; Tobé, TJ; Van Veldhuisen, DJ; Wiesfeld, AC | 1 |
Girbes, AR; Smit, AJ; van Veldhuisen, DJ | 1 |
Borchard, U | 1 |
Kleber, FX | 1 |
Theisen, K; Wehling, M | 1 |
Itoh, H; Taniguchi, K; Tsujibayashi, T | 1 |
Kleber, FX; Thyroff-Friesinger, U | 3 |
Costa, R; De Marino, V; Marino, A | 1 |
Bordoni, G; Castelli, N; Giannazzo, G; Mannolini, G; Pala, AM; Piccini, L | 1 |
Cesana, B; Ferrari, V; Licciardello, L; Sher, D; Sirtori, F | 1 |
Barabino, A; Galbariggi, G; Lotti, G; Pizzorni, C | 1 |
Cicchetti, V; Taylor, SH | 1 |
van Zwieten, PA | 1 |
Marchetti, GV | 1 |
Storstein, L | 1 |
Bruzzone, F; Canale, C; Caponnetto, S; Licciardello, L; Marchetti, GV; Masperone, MA; Pastorino, L; Terrachini, V | 1 |
Crijns, HJ; de Graeff, PA; Girbes, AR; Lie, KI; Smit, AJ; van Veldhuisen, DJ | 1 |
Casagrande, C; La Regina, A; Merlo, L | 1 |
Alunni, GF; Bardelli, G; Boschetti, E; Capponi, EA; Cocchieri, M; Del Favero, A; Fortunati, F; Regi, L | 1 |
Gerzer, R; Theisen, K; Wehling, M; Weil, J; Zimmermann, J | 1 |
Cutler, RE; Goldberg, P; Green, JA; Hricik, D; Jarvis, RC; Kasmer, RJ; Munger, MA; Nara, AR | 1 |
Man in 't Veld, AJ | 1 |
Holubarsch, C; Just, H | 1 |
Benzi, L; Cecchetti, P; Ciccarone, AM; Cicchetti, V; Di Cianni, G; Navalesi, R; Sabino, F | 1 |
Cicchetti, V; DiCarlo, A; Giannarelli, R; Marchetti, P; Navalesi, R; Sabino, F | 1 |
Theisen, K; Wehling, M; Zimmermann, J | 1 |
Azzolini, A; Colantoni, A; Guffanti, E; Pizzorni, C; Ronzitti, M; Tantalo, L | 1 |
Compostella, L; Cucchini, F; Di Mario, C; Ghirardi, P; Iavernaro, A; Libardoni, M | 1 |
Bruzzone, F; Canale, C; Caponnetto, S; Licciardello, L; Marchetti, GV; Terrachini, V | 1 |
Dei Cas, L; Metra, M; Nodari, S; Visioli, O | 1 |
Taylor, SH | 1 |
Casagrande, C; Ferrini, R; Merlo, L; Miragoli, G; Semeraro, C | 1 |
Dei Cas, L; Memo, M; Metra, M; Missale, C; Sigala, S; Spano, PF | 1 |
Alicandri, C; Boni, E; Fariello, R; Muiesan, G; Zaninelli, A | 1 |
Cantoni, V; Cicchetti, V; Ghirardi, P; Marchetti, GV; Rolandi, E; Sabino, F | 1 |
Bonaduce, A; Cacciapuoti, F; Canale, C; Caponnetto, S; Cappello, C; Condorelli, M; Mattioli, G; Montemurro, A; Terrachini, V; Varricchio, M | 1 |
Aggio, S; Ansani, L; Baracca, E; Ghirardi, P; Longhini, C; Musacci, GF; Toselli, T | 1 |
Carey, RA; Jacob, L | 1 |
Hasenfuss, G; Just, H | 1 |
Abbondati, G; Cavalli, A; Fuccella, LM; Riva, E; Schleman, M | 1 |
Abbondati, G; Cavalli, A; Cedrini, MC; Fuccella, LM; Riva, E; Schleman, M | 1 |
Barriales, V; Cortina, A; Martínez Trabanco, I; Richard, JM | 1 |
Hamada, M; Iwata, J; Kakuta, Y; Kasai, A; Konishi, T; Morimoto, Y; Nagano, K; Nakano, T; Umino, M | 1 |
Lodola, E; Ventresca, GP | 1 |
Byers, SL; Chaitman, BR; Labovitz, AJ; Mrosek, D; Stoddard, MF | 1 |
Bussmann, WD; Frik, R; Wienhöfer, K | 1 |
Isaka, N; Kakuta, Y; Kanamaru, M; Kodera, T; Konishi, T; Morimoto, Y; Nakano, T; Tekezawa, H | 1 |
Dei Cas, L; Manca, C; Metra, M; Nodari, S; Riva, S; Visioli, O | 1 |
Carini, L; Castini, D; Mazzola, C; Moreo, A; Salvadeo, A; Segagni, S; Segalini, G; Villa, G; Vitolo, E | 1 |
Bianco, L; Cantoni, V; Cicchetti, V; Ghirardi, P; Marchetti, GV; Sabino, F | 1 |
Azzollini, F; De Caro, L; Lodola, E; Longo, A; Pelosi, G; Rolandi, E; Ventresca, GP | 1 |
Gandini, C; Melloni, GF; Melloni, R; Scarazatti, E | 1 |
Lehto, H; Nieminen, MS; Partanen, J | 1 |
Azzollini, F; Castelnovo, P; Cattò, G; Iacuitti, G; Longo, A; Pataccini, R; Pelosi, G; Picca, M; Pocchiari, F; Ventresca, GP | 1 |
Conti, A; De Alfieri, W; Di Bari, M; Ferrucci, L; Lombardi, A; Marchionni, N; Moschi, G; Vannucci, A | 1 |
Allegro, A; Bellotti, G; Boccanelli, A; Caponnetto, S; Cataldi, A; Gambelli, G; Portioli, I; Prati, PL; Salvemini, M; Zacharo, E | 1 |
Kakuta, Y; Kanamaru, M; Kodera, T; Konishi, T; Morimoto, Y; Nakano, T; Takezawa, H | 1 |
Ferrari, V; Sher, D | 1 |
Marchetti, G; Merlo, L | 1 |
Colombo, G; De Vita, C; Devizzi, S; Palvarini, M; Pataccini, R; Pocchiari, F; Triulzi, E | 1 |
Castellaccio, M; Dore, L; Ibba, GV; Sannia, L | 1 |
Camerini, F; Humar, F; Maras, P; Morgera, T | 1 |
Bramucci, E; Gavazzi, A; Mussini, A | 1 |
Brusoni, B; Cadel, A; Carati, L; Fanciulli, R; Osculati, G; Pirelli, P; Rovati, A; Valagussa, F | 1 |
Aggio, S; Ansani, L; Baracca, E; Longhini, C; Musacci, GF; Toselli, T | 1 |
Barilli, AC; Cavicchi, E; Dei Cas, L; Fracalossi, C; Lomanto, B; Longhini, C; Maggi, GC; Metra, M; Pinca, L; Santambrogio, S | 1 |
Avanzini, Z; Bellogini, GC; Brusoni, B; Ciampani, N; Dei Cas, L; Gazzola, U; Maggi, GC; Mangiavacchi, M; Metra, M; Pinca, L | 1 |
Ferrari, V; Marchetti, G; Sher, D | 1 |
Castellaccio, M; Dore, L; Ibba, GV; Sannia, L; Scorcu, G | 1 |
Douglas, FL; Goldberg, LI; Karrison, T; Rajfer, SI; Rossen, JD | 1 |
Barreca, T; Cantoni, V; Cicchetti, V; Franceschini, R; Gianrossi, R; Marchetti, G; Rolandi, E | 1 |
Bianco, L; Brusoni, B; Col, J; Dei Cas, L; Ghirardi, P; Mangiavacchi, M; Metra, M | 1 |
Cicogna, R; Dei Cas, L; Fappani, A; Manca, C; Metra, M; Riva, S; Visioli, O | 1 |
Dei Cas, L; Faggiano, P; Fappani, A; Ferrari, R; Giunti, G; La Canna, G; Riva, S; Zanini, R | 1 |
30 review(s) available for ibopamine and Cardiac Failure
Article | Year |
---|---|
In search of the digitalis replacement.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1987 |
Receptor systems involved in norepinephrine release in heart failure: focus on dopaminergic systems.
Topics: Deoxyepinephrine; Dopamine Agonists; Heart Failure; Humans; Norepinephrine; Receptors, Dopamine | 1995 |
Neurohormonal and hemodynamic effects of ibopamine.
Topics: Clinical Trials as Topic; Deoxyepinephrine; Dopamine Agonists; Heart Failure; Hemodynamics; Humans; Kidney; Levodopa; Norepinephrine; Ventricular Dysfunction, Left | 1995 |
Clinical efficacy of ibopamine in patients with chronic heart failure.
Topics: Clinical Trials as Topic; Deoxyepinephrine; Dopamine Agonists; Heart Failure; Hemodynamics; Humans; Kidney; Norepinephrine; Randomized Controlled Trials as Topic | 1995 |
[Neurohormonal compensation processes in chronic heart failure: the effect of drugs].
Topics: Adrenergic beta-Agonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiac Glycosides; Cardiotonic Agents; Deoxyepinephrine; Diuretics; Dobutamine; Heart Failure; Humans; Receptors, Cell Surface; Renin-Angiotensin System; Sympathetic Nervous System | 1994 |
[Chronic cardiac insufficiency: current treatment and future outlook].
Topics: Adrenergic Antagonists; Aldosterone; Angiotensin II; Cardiotonic Agents; Cardiovascular Agents; Clinical Protocols; Deoxyepinephrine; Digitalis Glycosides; Diuretics; Heart Failure; Humans; Vasoconstrictor Agents | 1996 |
[Neurohormonal factors in heart failure (and III)].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Clinical Trials as Topic; Deoxyepinephrine; Diuretics; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Vasodilator Agents | 1996 |
Can drug effects on mortality in heart failure be predicted by any surrogate measure?
Topics: Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Biomarkers; Calcium Channel Blockers; Deoxyepinephrine; Dopamine Agonists; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate | 1997 |
Dopamine in heart failure and critical care.
Topics: Cardiotonic Agents; Controlled Clinical Trials as Topic; Critical Care; Deoxyepinephrine; Dopamine; Dopamine Agonists; Fenoldopam; Heart Failure; Hemodynamics; Humans; Treatment Outcome | 2000 |
[Exercise test in the evaluation of the efficacy of drug therapy].
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cardiotonic Agents; Clinical Trials as Topic; Deoxyepinephrine; Digitalis; Evaluation Studies as Topic; Exercise Test; Follow-Up Studies; Heart Failure; Humans; Oxygen Consumption; Plants, Medicinal; Plants, Toxic; Time Factors; Vasodilator Agents; Xamoterol | 2000 |
The underreporting of results and possible mechanisms of 'negative' drug trials in patients with chronic heart failure.
Topics: Bosentan; Cardiovascular Agents; Deoxyepinephrine; Heart Failure; Humans; Imidazoles; Mibefradil; Pyrazines; Quinolines; Sulfonamides; Xamoterol | 2001 |
[New oral drugs for the treatment of congestive heart failure].
Topics: Administration, Oral; Cardiotonic Agents; Deoxyepinephrine; Ethanolamines; Heart Failure; Humans; Phosphodiesterase Inhibitors; Piperidines; Propanolamines; Pyrazines; Quinolines; Quinolones; Vasodilator Agents; Xamoterol | 1992 |
Ibopamine in the treatment of heart failure.
Topics: Cardiotonic Agents; Deoxyepinephrine; Dopamine Agents; Heart Failure; Humans; Vasodilator Agents | 1991 |
Ibopamine in chronic congestive heart failure: hemodynamic and neurohumoral effects.
Topics: Animals; Cardiotonic Agents; Deoxyepinephrine; Dopamine Agents; Heart; Heart Failure; Hemodynamics; Humans; Neurotransmitter Agents; Vasodilator Agents | 1991 |
[Ibopamine--pharmacologic principles].
Topics: Cardiotonic Agents; Deoxyepinephrine; Dopamine Agents; Heart; Heart Failure; Hemodynamics; Humans; Receptors, Adrenergic; Receptors, Dopamine | 1991 |
[Ibopamine--clinical results].
Topics: Cardiotonic Agents; Deoxyepinephrine; Dopamine Agents; Heart; Heart Failure; Hemodynamics; Humans; Kidney Function Tests; Prognosis | 1991 |
[Ibopamine--acute hemodynamic, renal and neurohumoral effects].
Topics: Cardiotonic Agents; Deoxyepinephrine; Dopamine Agents; Heart; Heart Failure; Hemodynamics; Hormones; Humans; Kidney Function Tests | 1991 |
[Physiological bases and therapeutic uses of inodilator drugs].
Topics: Amrinone; Cardiotonic Agents; Deoxyepinephrine; Dobutamine; Dopamine; Heart Failure; Humans; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Sympathomimetics; Vasodilator Agents | 1991 |
Efficacy of ibopamine in the treatment of heart failure.
Topics: Cardiotonic Agents; Deoxyepinephrine; Dopamine Agents; Heart Failure; Humans; Vasodilator Agents | 1990 |
Pharmacological profile of ibopamine. A summary of experiments on anaesthesized dogs.
Topics: Animals; Cardiotonic Agents; Deoxyepinephrine; Dogs; Dopamine Agents; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Receptors, Adrenergic; Receptors, Dopamine; Vasodilator Agents | 1990 |
Effect of ibopamine, a dopamine congener, on arrhythmias in heart failure.
Topics: Animals; Cardiotonic Agents; Deoxyepinephrine; Dopamine Agents; Electrocardiography, Ambulatory; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Tachycardia; Vasodilator Agents | 1990 |
Hemodynamic and neurohumoral effects of ibopamine in patients with chronic congestive heart failure.
Topics: Cardiotonic Agents; Deoxyepinephrine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Long-Term Care; Neurotransmitter Agents; Vasodilator Agents | 1990 |
Development of dopaminergic drugs for the chronic treatment of congestive heart failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Deoxyepinephrine; Dopamine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Receptors, Dopamine | 1990 |
How to select a drug for the long-term treatment of chronic heart failure.
Topics: Cardiotonic Agents; Deoxyepinephrine; Heart Failure; Humans | 1990 |
The safety profile of ibopamine, an alternative substance for treatment of chronic heart failure.
Topics: Cardiotonic Agents; Deoxyepinephrine; Electrocardiography; Heart Failure; Hemodynamics; Humans; Vasodilator Agents; Water-Electrolyte Balance | 1990 |
Pharmacotherapeutic profile of ibopamine in heart failure.
Topics: Adrenergic beta-Agonists; Aged; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Dopamine Agents; Heart Failure; Hemodynamics; Humans; Middle Aged; Receptors, Adrenergic, beta; Receptors, Dopamine; Renin-Angiotensin System; Vasodilator Agents | 1989 |
Cardiovascular and renal action of dopaminergic prodrugs.
Topics: Animals; Cardiotonic Agents; Cats; Chemical Phenomena; Chemistry; Deoxyepinephrine; Dihydroxyphenylalanine; Dogs; Dopamine; Dopamine Agents; Drug Design; Female; Heart Failure; Hemodynamics; Humans; Kidney; Levodopa; Male; Prodrugs; Rabbits; Rats; Vasodilator Agents | 1989 |
The role of dopaminergic agents and the dopamine receptor in treatment for CHF.
Topics: Benzazepines; Deoxyepinephrine; Dobutamine; Dopamine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Receptors, Dopamine | 1989 |
Clinical relevance of long-term therapy with levodopa and orally active dopamine analogues in patients with chronic congestive heart failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Administration, Oral; Chronic Disease; Deoxyepinephrine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Vasodilator Agents | 1989 |
Ibopamine--how should it be used?
Topics: Cardiotonic Agents; Clinical Trials as Topic; Deoxyepinephrine; Dopamine; Heart Failure; Hemodynamics; Humans | 1988 |
51 trial(s) available for ibopamine and Cardiac Failure
Article | Year |
---|---|
Low pulse pressure is an independent predictor of mortality and morbidity in non ischaemic, but not in ischaemic advanced heart failure patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Blood Pressure; Deoxyepinephrine; Disease Progression; Dopamine Agonists; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Young Adult | 2009 |
[Echocardiographic and polygraphic study of acute/effects of Ibopamine on cardiac performance].
Topics: Adult; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Echocardiography; Heart; Heart Failure; Hemodynamics; Humans; Male | 1983 |
Failure of "effective" treatment for heart failure to improve normal customary activity.
Topics: Activities of Daily Living; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Deoxyepinephrine; Dopamine Agonists; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Indoles; Isosorbide Dinitrate; Male; Middle Aged; Single-Blind Method; Treatment Failure; Vasodilator Agents | 1995 |
[Acute hemodynamic effects of ibopamine, captopril, and placebo in patients with severe heart failure].
Topics: Adolescent; Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathies; Deoxyepinephrine; Diuretics; Double-Blind Method; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Rest; Severity of Illness Index | 1995 |
Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group.
Topics: Aldosterone; Cardiotonic Agents; Deoxyepinephrine; Digoxin; Diuretics; Dopamine Agonists; Double-Blind Method; Electrocardiography, Ambulatory; Female; Furosemide; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Renin; Time Factors | 1995 |
[Comparative study between ibopamine and captopril in mild and moderate heart failure. A double-blind study].
Topics: Adult; Aged; Captopril; Cardiotonic Agents; Clinical Protocols; Deoxyepinephrine; Double-Blind Method; Electrocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged | 1994 |
Dopaminergic drugs in congestive heart failure: hemodynamic and neuroendocrine responses to ibopamine, dopamine, and dihydroergotoxine.
Topics: Administration, Oral; Aged; Aldosterone; Analysis of Variance; Blood Pressure; Deoxyepinephrine; Dihydroergotoxine; Dopamine; Dopamine Agonists; Epinephrine; Heart Failure; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Norepinephrine; Radionuclide Imaging; Renin; Stroke Volume; Vascular Resistance | 1995 |
Renal and systemic hemodynamic effects of ibopamine in patients with mild to moderate congestive heart failure.
Topics: Aged; Aldosterone; Deoxyepinephrine; Female; Heart Failure; Hemodynamics; Humans; Kidney Function Tests; Male; Middle Aged; Renal Circulation; Renin; Sodium; Vasodilator Agents | 1995 |
Acute effect of ibopamine and isosorbide mononitrate on blood volume distribution in congestive heart failure.
Topics: Aged; Blood Volume; Deoxyepinephrine; Double-Blind Method; Drug Interactions; Female; Heart Failure; Hemodynamics; Humans; Isosorbide; Male; Middle Aged; Radionuclide Imaging; Technetium Tc 99m Pentetate | 1994 |
Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT).
Topics: Adolescent; Adult; Aged; Aldosterone; Cardiotonic Agents; Deoxyepinephrine; Digoxin; Dopamine Agents; Double-Blind Method; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Netherlands; Norepinephrine; Prospective Studies; Renin; Severity of Illness Index | 1993 |
Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor.
Topics: Aged; Coronary Disease; Deoxyepinephrine; Dopamine Agents; Double-Blind Method; Down-Regulation; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Receptors, Dopamine; Ventricular Function, Left | 1994 |
The effects of oral ibopamine in patients with mild heart failure--a double blind placebo controlled comparison to furosemide. The Ibopamine Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cardiac Output; Cardiotonic Agents; Child; Deoxyepinephrine; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Exercise Test; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Quality of Life | 1993 |
Clinical and autonomic effects of ibopamine as adjunct to angiotensin-converting enzyme inhibitors in chronic heart failure.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Autonomic Nervous System; Blood Gas Analysis; Cardiotonic Agents; Chemotherapy, Adjuvant; Chronic Disease; Deoxyepinephrine; Double-Blind Method; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Radioimmunoassay; Renin | 1996 |
Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators.
Topics: Adult; Aged; Aged, 80 and over; Cause of Death; Deoxyepinephrine; Dopamine Agonists; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Survival Rate; Treatment Outcome | 1997 |
A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure.
Topics: Adult; Cross-Over Studies; Deoxyepinephrine; Diuretics; Dopamine Agonists; Double-Blind Method; Exercise Test; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1997 |
Ibopamine and survival in severe congestive heart failure: PRIME II.
Topics: Cardiotonic Agents; Cause of Death; Deoxyepinephrine; Drug Monitoring; Heart Failure; Humans; Placebos; Safety; Stochastic Processes; Survival Rate | 1997 |
Ibopamine and survival in severe congestive heart failure: PRIME II.
Topics: Amiodarone; Anti-Arrhythmia Agents; Area Under Curve; Cardiotonic Agents; Cause of Death; Deoxyepinephrine; Dopamine Agonists; Heart Failure; Humans; Survival Rate | 1997 |
Comparison of captopril and ibopamine in mild to moderate heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Deoxyepinephrine; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies | 1997 |
Evaluation of ibopamine plus prazosin in congestive heart failure.
Topics: Adrenergic alpha-Antagonists; Adult; Cross-Over Studies; Deoxyepinephrine; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Monitoring, Physiologic; Placebos; Prazosin; Vasodilator Agents | 1998 |
Renal function, neurohormonal activation, and survival in patients with chronic heart failure.
Topics: Aged; Aldosterone; Atrial Natriuretic Factor; Cardiac Output; Cardiotonic Agents; Catecholamines; Chronic Disease; Deoxyepinephrine; Dopamine; Epinephrine; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Male; Middle Aged; New York; Norepinephrine; Predictive Value of Tests; Prognosis; Prospective Studies; Protein Precursors; Renin; Renin-Angiotensin System; Survival Analysis; Ventricular Dysfunction, Left; Ventricular Function, Left | 2000 |
Achieving appropriate endpoints in heart failure trials: the PRIME-II protocol. The Second Perspective Randomised study of Ibopamine on Mortality and Efficacy.
Topics: Clinical Protocols; Deoxyepinephrine; Evaluation Studies as Topic; Heart Failure; Humans; Patient Selection; Randomized Controlled Trials as Topic; Research Design; Risk Assessment; Survival Analysis; Vasodilator Agents | 1999 |
Effects of acute and chronic ibopamine administration on resting and exercise hemodynamics, plasma catecholamines and functional capacity of patients with chronic congestive heart failure.
Topics: Deoxyepinephrine; Dopamine Agents; Double-Blind Method; Epinephrine; Exercise; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Time Factors | 1992 |
[Ibopamine in the treatment of congestive heart failure. Multicenter follow-up study].
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Deoxyepinephrine; Drug Evaluation; Female; Heart Failure; Humans; Male; Middle Aged; Portugal; Prospective Studies | 1992 |
Hemodynamic comparison of combined therapy by nitroglycerin tape and ibopamine with combination of nitroglycerin tape and nifedipine.
Topics: Administration, Cutaneous; Administration, Oral; Cardiac Complexes, Premature; Cardiotonic Agents; Deoxyepinephrine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Nifedipine; Nitroglycerin; Vasodilator Agents | 1990 |
[Ibopamine in treatment of mild heart failure, a comparison with hydrochlorothiazide].
Topics: Aged; Cardiotonic Agents; Deoxyepinephrine; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Hydrochlorothiazide; Male | 1991 |
Safety of ibopamine therapy in congestive heart failure. Ibopamine cohort study: baseline and 1-year results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Cardiotonic Agents; Deoxyepinephrine; Digoxin; Drug Prescriptions; Drug Therapy, Combination; Electrocardiography; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Product Surveillance, Postmarketing; Prognosis; Risk Factors | 1991 |
Comparative effects of long-term therapy with captopril and ibopamine in chronic congestive heart failure in old patients.
Topics: Aged; Captopril; Deoxyepinephrine; Double-Blind Method; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Male; Time Factors; Vasodilator Agents | 1991 |
Comparative effects of ibopamine and captopril in mild congestive heart failure. Focus on the long-term effects of inodilation on ventricular arrhythmias.
Topics: Adult; Aged; Captopril; Cardiotonic Agents; Deoxyepinephrine; Double-Blind Method; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Long-Term Care; Middle Aged; Tachycardia; Vasodilator Agents | 1990 |
[Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure].
Topics: Atrial Natriuretic Factor; Blood Pressure; Cardiomyopathy, Dilated; Coronary Disease; Cyclic GMP; Deoxyepinephrine; Diuretics; Dopamine; Electrolytes; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Natriuresis; Urodynamics | 1990 |
Single-dose effects of ibopamine hydrochloride on renal function in patients with congestive heart failure.
Topics: Acute Kidney Injury; Administration, Oral; Aged; Deoxyepinephrine; Diuretics; Female; Heart Failure; Humans; Kidney Function Tests; Male; Middle Aged; Osmolar Concentration; Potassium; Sodium | 1990 |
Ibopamine does not affect insulin resistance in patients with type I diabetes.
Topics: Adult; Blood Glucose; Cardiotonic Agents; Deoxyepinephrine; Diabetes Mellitus, Type 1; Female; Heart Failure; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Vasodilator Agents | 1990 |
Safety of ibopamine in type II diabetic patients with mild chronic heart failure. A double-blind cross-over study.
Topics: Aged; C-Peptide; Cardiotonic Agents; Deoxyepinephrine; Diabetes Mellitus, Type 2; Double-Blind Method; Fatty Acids, Nonesterified; Female; Glucose Tolerance Test; Heart Failure; Hemodynamics; Humans; Lactates; Lactic Acid; Male; Vasodilator Agents | 1990 |
Treatment of mild chronic congestive heart failure with ibopamine, hydrochlorothiazide, ibopamine plus hydrochlorothiazide or placebo. A double-blind comparative study.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Deoxyepinephrine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Hydrochlorothiazide; Male; Middle Aged; Vasodilator Agents; Water-Electrolyte Balance | 1990 |
Ibopamine versus digoxin in the treatment of mild congestive heart failure. A double-blind, randomized, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Deoxyepinephrine; Digoxin; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Vasodilator Agents | 1990 |
Extracardial effects of oral ibopamine versus furosemide in patients with mild or moderate heart failure. A double-blind, randomized trial.
Topics: Administration, Oral; Adult; Cardiotonic Agents; Deoxyepinephrine; Double-Blind Method; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Renal Circulation; Renin; Vasodilator Agents; Water-Electrolyte Balance | 1990 |
Ibopamine in the treatment of mild chronic heart failure in elderly patients. A double-blind, placebo-controlled study.
Topics: Aged; Cardiotonic Agents; Deoxyepinephrine; Double-Blind Method; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Vasodilator Agents | 1990 |
Absence of proarrhythmic effects of ibopamine in patients with congestive heart failure.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Double-Blind Method; Drug Evaluation; Female; Heart Failure; Humans; Italy; Male; Middle Aged; Multicenter Studies as Topic; Random Allocation; Vasodilator Agents | 1989 |
Inhibition of aldosterone secretion by dopamine, ibopamine, and dihydroergotoxine in patients with congestive heart failure.
Topics: Aged; Aldosterone; Deoxyepinephrine; Depression, Chemical; Dihydroergotoxine; Dopamine; Dopamine Agents; Heart Failure; Humans; Male; Middle Aged; Random Allocation; Renin; Renin-Angiotensin System | 1989 |
Ibopamine vs. digoxin in chronic heart failure: a double-blind, crossover study.
Topics: Adult; Aged; Cardiotonic Agents; Chronic Disease; Deoxyepinephrine; Digoxin; Dopamine; Double-Blind Method; Drug Evaluation; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Oxygen Consumption; Physical Endurance; Random Allocation; Vasodilator Agents | 1989 |
Long-term therapy of chronic congestive heart failure with ibopamine: a multicenter trial.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Chronic Disease; Deoxyepinephrine; Dopamine; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Italy; Male; Middle Aged; Multicenter Studies as Topic; Survival Rate; Time Factors; Vasodilator Agents | 1989 |
The long-term efficacy of ibopamine in treating patients with severe heart failure: a multicenter investigation.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Clinical Trials as Topic; Deoxyepinephrine; Digitalis Glycosides; Diuretics; Dopamine; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Female; Heart Failure; Humans; Italy; Male; Middle Aged; Multicenter Studies as Topic; Physical Endurance; Random Allocation; Time Factors; Vasodilator Agents | 1989 |
Peripheral hemodynamic effects of ibopamine in patients with congestive heart failure. A placebo-controlled, double-blind study.
Topics: Aged; Aged, 80 and over; Deoxyepinephrine; Double-Blind Method; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Plethysmography; Regional Blood Flow; Sulpiride; Vasodilator Agents | 1989 |
Ibopamine versus hydrochlorothiazide/amiloride in patients with mild congestive heart failure. SK & F Ibopamine Working Group.
Topics: Amiloride; Body Weight; Cardiotonic Agents; Deoxyepinephrine; Double-Blind Method; Drug Combinations; Exercise Test; Female; Heart Failure; Humans; Hydrochlorothiazide; Male; Middle Aged; Vasodilator Agents | 1989 |
Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Double-Blind Method; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Multicenter Studies as Topic | 1989 |
Ibopamine as a substitute for digitalis in patients with congestive heart failure on chronic digoxin therapy. Smith Kline and French Ibopamine Group.
Topics: Adult; Aged; Arrhythmias, Cardiac; Deoxyepinephrine; Digoxin; Dopamine; Echocardiography; Exercise Test; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged | 1989 |
Ibopamine--how should it be used?
Topics: Cardiotonic Agents; Clinical Trials as Topic; Deoxyepinephrine; Dopamine; Heart Failure; Hemodynamics; Humans | 1988 |
Effects of ibopamine in combination with furosemide on renal function in patients with chronic congestive heart failure.
Topics: Aged; Blood Glucose; Chlorides; Creatinine; Deoxyepinephrine; Dopamine; Drug Therapy, Combination; Electrolytes; Female; Furosemide; Heart Failure; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Urination | 1988 |
Positive inotropic effects of ibopamine in patients with congestive heart failure. A multicenter investigation.
Topics: Adult; Aged; Blood Chemical Analysis; Cardiotonic Agents; Clinical Trials as Topic; Deoxyepinephrine; Dopamine; Double-Blind Method; Electrocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Random Allocation | 1986 |
Ibopamine post-marketing surveillance. First report from a parallel-cohorts survey ongoing since April 1st, 1985.
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Cardiotonic Agents; Cardiovascular Diseases; Deoxyepinephrine; Dopamine; Drug Interactions; Electrocardiography; Evaluation Studies as Topic; Female; Heart Failure; Humans; Male; Middle Aged; Product Surveillance, Postmarketing; Prognosis; Risk Factors; Sex Factors; Socioeconomic Factors; Thromboembolism | 1987 |
Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
Topics: Adult; Cardiac Output; Cardiotonic Agents; Chronic Disease; Deoxyepinephrine; Dopamine; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1986 |
Effects of digoxin, placebo and ibopamine on exercise tolerance and cardiac rhythm of patients with chronic post-infarct left ventricular failure.
Topics: Aged; Arrhythmias, Cardiac; Cardiotonic Agents; Deoxyepinephrine; Digoxin; Dopamine; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Physical Exertion | 1986 |
69 other study(ies) available for ibopamine and Cardiac Failure
Article | Year |
---|---|
Sympathomimetic amines: potential clinical applications in ischemic heart disease.
Topics: Animals; Coronary Disease; Deoxyepinephrine; Dobutamine; Dogs; Dopamine; Heart Failure; Humans; Levodopa; Myocardial Contraction; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Dopamine; Sympathomimetics | 1982 |
Haemodynamic evaluation of ibopamine in severe congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Electrocardiography; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Stroke Volume | 1984 |
Ibopamine in very severe congestive heart failure: pilot haemodynamic invasive assessment.
Topics: Aged; Blood Pressure; Cardiac Output; Deoxyepinephrine; Diuretics; Dopamine; Heart Failure; Hemodynamics; Humans; Middle Aged; Time Factors | 1983 |
[Preliminary results of the action of long-term oral treatment with the di-isobutyric ester of N-methyldopamine (SB 7505) in 10 patients with severe cardiocirculatory decompensation].
Topics: Aged; Aortic Valve; Blood Pressure; Cardiomyopathies; Deoxyepinephrine; Diuresis; Diuretics; Dopamine; Heart Failure; Heart Valve Diseases; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Stroke Volume; Systole | 1980 |
Double-blind haemodynamic study of a new dopamine derivative (diisobutyric ester of N-methyl-dopamine) orally active in chronic congestive heart failure.
Topics: Aged; Blood Pressure; Deoxyepinephrine; Dopamine; Double-Blind Method; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Circulation; Vascular Resistance | 1981 |
The effects of ibopamine on glomerular filtration rate and plasma norepinephrine remain preserved during prolonged treatment in patients with congestive heart failure.
Topics: Adult; Aged; Aldosterone; Deoxyepinephrine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Kidney; Long-Term Care; Male; Middle Aged; Norepinephrine; Renin | 1995 |
Pharmacologic treatment of congestive heart failure.
Topics: Cardiotonic Agents; Deoxyepinephrine; Diuretics; Heart Failure; Humans; Vasodilator Agents | 1995 |
Congestive heart failure. Drug therapy: central or peripheral approach?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Carnitine; Coenzymes; Deoxyepinephrine; Dopamine Agents; Heart Failure; Humans; Taurine; Ubiquinone; Vasodilator Agents | 1993 |
[Drug of the month. Ibopamine (Scandine, Idopamil)].
Topics: Cardiotonic Agents; Deoxyepinephrine; Heart Failure; Humans; Vasodilator Agents | 1994 |
Effects of ibopamine on renal haemodynamics in patients with severe congestive heart failure.
Topics: Aged; Aged, 80 and over; Deoxyepinephrine; Dopamine Agents; Drug Evaluation; Glomerular Filtration Rate; Heart Failure; Humans; Middle Aged; Potassium; Renal Circulation; Sodium | 1993 |
[The neurohumoral mechanisms are already altered before the patient may have symptoms of heart failure. Interview by Salvador Giménez].
Topics: Deoxyepinephrine; Dopamine Agents; Heart Failure; Humans; Neurotransmitter Agents | 1993 |
Ibopamine-induced reversible leukopenia during treatment for congestive heart failure.
Topics: Aged; Aged, 80 and over; Deoxyepinephrine; Dopamine Agents; Female; Heart Failure; Humans; Leukopenia | 1993 |
Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine.
Topics: Animals; Aortic Valve Stenosis; Culture Techniques; Deoxyepinephrine; Disease Models, Animal; Endothelium, Vascular; Epinephrine; Heart Failure; Male; Methacholine Chloride; Myocardial Infarction; Norepinephrine; Phenylephrine; Rats; Rats, Wistar; Vasodilator Agents | 1993 |
Effects of ibopamine on the increase in plasma norepinephrine levels during exercise in congestive heart failure.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Deoxyepinephrine; Female; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Physical Exertion | 1993 |
[Clinical efficacy of oral dopaminergic agents: new findings].
Topics: Administration, Oral; Adrenergic alpha-Agonists; Deoxyepinephrine; Dopamine; Dopamine Agents; Dopamine Agonists; Heart Failure; Hemodynamics; Humans; Kidney; Levodopa; Norepinephrine; Receptors, Dopamine | 1995 |
[Refractory heart failure: it requires the use of polychemotherapy. What is the rationale?].
Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Cyclooxygenase Inhibitors; Deoxyepinephrine; Digitalis Glycosides; Diuretics; Dobutamine; Dopamine; Dopamine Agonists; Drug Therapy, Combination; Heart Failure; Humans; Nitrates; Phosphodiesterase Inhibitors; Vasodilator Agents | 1995 |
Treating chronic heart failure: time to take stock.
Topics: Chronic Disease; Deoxyepinephrine; Dopamine Agonists; Heart Failure; Humans; Randomized Controlled Trials as Topic; Receptors, Dopamine | 1997 |
Treatment of mild heart failure: the place of diuretics and ibopamine.
Topics: Chronic Disease; Deoxyepinephrine; Diuretics; Dopamine Agonists; Drug Therapy, Combination; Heart Failure; Humans; Survival Rate | 1997 |
PRIME II (Second Prospective Randomized Study of Ibupamine on Mortality and Efficacy): another disappointment in heart failure therapy.
Topics: Deoxyepinephrine; Dopamine Agonists; Drug Evaluation; Heart Failure; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Safety; Survival Rate; Vasodilator Agents | 1997 |
Dopamine agonists in heart failure: an untimely death.
Topics: Deoxyepinephrine; Dopamine Agonists; Heart Failure; Humans; Netherlands | 1997 |
A nested case-control study on mortality in users of ibopamine.
Topics: Aged; Case-Control Studies; Deoxyepinephrine; Dopamine Agonists; Female; Heart Failure; Humans; Logistic Models; Male; Netherlands; Odds Ratio; Risk Factors | 1997 |
Risk factors for mortality in users of ibopamine.
Topics: Aged; Cohort Studies; Deoxyepinephrine; Dopamine Agonists; Female; Heart Failure; Humans; Male; Middle Aged; Netherlands; Risk Factors | 1998 |
[Risk factors for dying among ibopamine users].
Topics: Adult; Aged; Cardiotonic Agents; Clinical Trials as Topic; Deoxyepinephrine; Female; Heart Failure; Humans; Male; Middle Aged; Risk Factors; Survival Rate | 1999 |
[Risk factors for dying among ibopamine users].
Topics: Aged; Cardiotonic Agents; Clinical Trials as Topic; Deoxyepinephrine; Heart Failure; Humans; Risk Factors | 1999 |
Confounding by contraindication in a nationwide cohort study of risk for death in patients taking ibopamine.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Cohort Studies; Confounding Factors, Epidemiologic; Contraindications; Deoxyepinephrine; Dopamine Agonists; Female; Heart Failure; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Surveys and Questionnaires | 2001 |
Ibopamine as a valuable adjunct and substitute for dopamine in bridging therapy before heart transplantation.
Topics: Adult; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Drug Therapy, Combination; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Postoperative Complications; Preoperative Care | 1992 |
Effects of intravenous epinine administration on left ventricular systolic performance, coronary hemodynamics, and circulating catecholamines in patients with heart failure.
Topics: Adult; Aged; Catecholamines; Coronary Circulation; Deoxyepinephrine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Ventricular Function, Left | 1992 |
Hemodynamic effects and pharmacokinetics of long-term therapy with ibopamine in patients with chronic heart failure.
Topics: Administration, Oral; Aged; Cardiotonic Agents; Chronic Disease; Deoxyepinephrine; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Long-Term Care; Male; Metabolic Clearance Rate; Middle Aged | 1992 |
Ibopamine: a new pharmacotherapeutic approach to heart failure. Proceedings of a symposium. October 19, 1989, Kyoto, Japan.
Topics: Deoxyepinephrine; Dopamine Agents; Heart Failure; Humans | 1991 |
Dopaminergic drugs in the management of chronic heart failure.
Topics: Adult; Deoxyepinephrine; Dopamine Agents; Female; Heart Failure; Hemodynamics; Humans; Levodopa; Male; Middle Aged; Myocardial Contraction; Pilot Projects | 1991 |
Electrophysiologic profile of ibopamine in patients with congestive heart failure and ventricular tachycardia and relation to its effects on hemodynamics and plasma catecholamines.
Topics: Adult; Aged; Blood Pressure; Cardiac Pacing, Artificial; Catecholamines; Deoxyepinephrine; Dopamine Agents; Electrocardiography; Electrocardiography, Ambulatory; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Stroke Volume; Tachycardia; Vascular Resistance | 1991 |
Dopamine agonists, a new perspective in cardiovascular therapy?
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Deoxyepinephrine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic | 1991 |
[Changes in the cardio-thoracic index during the treatment with ibopamine].
Topics: Administration, Oral; Aged; Aged, 80 and over; Cardiotonic Agents; Deoxyepinephrine; Female; Heart Failure; Humans; Middle Aged; Radiography, Thoracic; Time Factors; Vasodilator Agents | 1991 |
[Dopamine and dopaminergic drugs as therapeutic agents in heart failure].
Topics: Deoxyepinephrine; Dobutamine; Dopamine; Dopamine Agents; Heart Failure; Hemodynamics; Humans; Vasodilator Agents | 1990 |
Long-term treatment of congestive heart failure with oral ibopamine. Effects of rhythm disorders and neurohormonal alterations.
Topics: Administration, Oral; Aged; Aldosterone; Angiotensin II; Arrhythmias, Cardiac; Cardiotonic Agents; Deoxyepinephrine; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Heart Failure; Hemodynamics; Humans; Long-Term Care; Male; Middle Aged; Neurotransmitter Agents; Norepinephrine; Renin; Vasodilator Agents | 1990 |
Efficacy and safety of ibopamine in congestive heart failure.
Topics: Adult; Aged; Aged, 80 and over; Deoxyepinephrine; Dopamine Agents; Drug Evaluation; Electrocardiography; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Safety | 1990 |
Ibopamine in the management of congestive heart failure.
Topics: Deoxyepinephrine; Heart Failure; Humans | 1990 |
Onset of cardiovascular action after oral ibopamine. Early hemodynamic effects of single and repeated doses in patients with idiopathic dilated myocardiopathy.
Topics: Aged; Blood Pressure; Cardiac Output; Cardiomyopathy, Dilated; Deoxyepinephrine; Dopamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Circulation; Vasodilator Agents | 1990 |
Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
Topics: Administration, Oral; Adult; Cardiotonic Agents; Creatinine; Deoxyepinephrine; Dopamine; Drug Administration Schedule; Drug Evaluation; Echocardiography; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Sodium; Survival Rate; Vasodilator Agents | 1989 |
Ibopamine: long-term safety study in patients with congestive heart failure. The Italian Ibopamine Working Group.
Topics: Adolescent; Adult; Aged; Cardiotonic Agents; Demography; Deoxyepinephrine; Diuretics; Dopamine; Drug Tolerance; Female; Heart Failure; Humans; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Time Factors; Vasodilator Agents | 1989 |
[Role of ibopamine in cardiac insufficiency in auricular fibrillation. Presentation of a case].
Topics: Aged; Atrial Fibrillation; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Heart Failure; Humans; Male | 1989 |
[Acute and chronic effects of a new oral inotropic agent, ibopamine hydrochloride, on hemodynamic and metabolic responses to ergometer exercise in patients with severe congestive heart failure].
Topics: Administration, Oral; Adult; Aged; Cardiotonic Agents; Deoxyepinephrine; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1989 |
Dopamine receptors: applications in clinical cardiology.
Topics: Administration, Oral; Arrhythmias, Cardiac; Benzazepines; Bromocriptine; Deoxyepinephrine; Fenoldopam; Heart Failure; Hemodynamics; Humans; Levodopa; Receptors, Dopamine; Structure-Activity Relationship; Vascular Resistance | 1985 |
The role of adrenergic and dopamine receptors.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiotonic Agents; Deoxyepinephrine; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Levodopa; Receptors, Adrenergic; Receptors, Dopamine | 1985 |
Clinical pharmacokinetics of ibopamine on different diseases and conditions.
Topics: Absorption; Administration, Oral; Adult; Aged; Aged, 80 and over; Biological Availability; Chemical Phenomena; Chemistry; Deoxyepinephrine; Digoxin; Dopamine; Dopamine Agents; Drug Interactions; Female; Food; Heart Failure; Humans; Kidney Failure, Chronic; Liver Cirrhosis; Male; Middle Aged; Quinidine; Vasodilator Agents | 1988 |
Noninvasive assessment of diastolic and systolic properties of ibopamine in patients with congestive heart failure.
Topics: Adult; Aged; Deoxyepinephrine; Diastole; Dopamine; Echocardiography; Echocardiography, Doppler; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Systole | 1989 |
[Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure].
Topics: Aged; Aged, 80 and over; Aldosterone; Carbon Dioxide; Cardiotonic Agents; Catecholamines; Deoxyepinephrine; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Male; Oxygen; Renin | 1987 |
Lack of tolerance development during chronic ibopamine administration to patients with congestive heart failure.
Topics: Adult; Aged; Chronic Disease; Deoxyepinephrine; Drug Tolerance; Heart Failure; Humans; Male; Middle Aged; Vasodilator Agents | 1988 |
Treatment of heart failure following chronic cor pulmonale with ibopamine.
Topics: Aged; Aged, 80 and over; Chronic Disease; Deoxyepinephrine; Diuretics; Dopamine; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Male; Middle Aged; Pulmonary Heart Disease | 1988 |
Ibopamine kinetics after single and multiple dosing in patients with congestive heart failure.
Topics: Aged; Deoxyepinephrine; Dopamine; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Middle Aged | 1988 |
[Blood levels of activated renin, aldosterone, catecholamine in congestive heart failure. II. Effects of dopaminergic stimulation with a dopamine agonist: ibopamine].
Topics: Adult; Aldosterone; Blood Volume; Catecholamines; Deoxyepinephrine; Dopamine; Female; Heart Failure; Humans; Male; Middle Aged; Renin | 1987 |
Effect of ibopamine on the failing heart at rest and during isometric exercise: a noninvasive study.
Topics: Adult; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Heart Failure; Hemodynamics; Humans; Isometric Contraction; Male; Middle Aged; Rest | 1988 |
Ibopamine kinetics after a single oral dose in patients with congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Chromatography, High Pressure Liquid; Deoxyepinephrine; Dopamine; Female; Half-Life; Heart Failure; Humans; Male; Middle Aged; Vasodilator Agents | 1988 |
Ibopamine in congestive heart failure refractory to digitalis, diuretics, and captopril.
Topics: Aged; Captopril; Cardiotonic Agents; Creatinine; Deoxyepinephrine; Digitalis Glycosides; Diuretics; Dopamine; Drug Resistance; Echocardiography; Electrocardiography; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Sodium | 1986 |
Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure.
Topics: Aged; Aldosterone; Blood Gas Analysis; Cardiotonic Agents; Catecholamines; Deoxyepinephrine; Dopamine; Electrolytes; Female; Heart Failure; Heart Function Tests; Hemodynamics; Humans; Male; Renin | 1986 |
Effects of ibopamine on acute cardiac failure following experimental coronary occlusion in dogs.
Topics: Animals; Cardiotonic Agents; Coronary Disease; Deoxyepinephrine; Dogs; Dopamine; Electrocardiography; Female; Heart Failure; Hemodynamics; Male | 1986 |
Evaluation of acute hemodynamic effects and pharmacokinetic behaviour of ibopamine in patients with severe heart failure.
Topics: Adult; Aged; Deoxyepinephrine; Diuretics; Dopamine; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Kinetics; Male; Middle Aged; Time Factors; Vascular Resistance | 1986 |
Hemodynamic evaluation of ibopamine in patients with refractory congestive heart failure.
Topics: Adult; Aged; Cardiac Catheterization; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Drug Resistance; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Time Factors | 1986 |
Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure.
Topics: Adult; Aged; Cardiac Catheterization; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Time Factors | 1986 |
Effects of ibopamine on peripheral hemodynamics: a strain gauge plethysmographic study in patients with congestive heart failure.
Topics: Aged; Blood Pressure; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Plethysmography; Regional Blood Flow; Time Factors | 1986 |
Multicenter study on the clinical efficacy of chronic ibopamine administration.
Topics: Aged; Blood Pressure; Cardiotonic Agents; Deoxyepinephrine; Diuresis; Dopamine; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged | 1986 |
Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure.
Topics: Adult; Aged; Body Weight; Cardiotonic Agents; Chronic Disease; Deoxyepinephrine; Dopamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Monitoring, Physiologic; Time Factors | 1986 |
A survey of 311 patients receiving ibopamine mainly during hospital treatment for severe congestive heart failure.
Topics: Age Factors; Aged; Blood Pressure; Body Weight; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Monitoring, Physiologic; Sex Factors | 1986 |
[Comparison of the acute effects of ibopamine with those of dopamine on the echocardiographic parameters of systolic function of the heart in congestive cardiac failure].
Topics: Adult; Aged; Deoxyepinephrine; Dopamine; Echocardiography; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Systole | 1986 |
Effects of long-term therapy with oral ibopamine on resting hemodynamics and exercise capacity in patients with heart failure: relationship to the generation of N-methyldopamine and to plasma norepinephrine levels.
Topics: Administration, Oral; Cardiac Output; Deoxyepinephrine; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Physical Exertion; Pulmonary Wedge Pressure; Rest; Stroke Volume; Time Factors | 1986 |
Inhibition of prolactin and aldosterone secretion by the dopamine derivative ibopamine.
Topics: Adult; Aldosterone; Deoxyepinephrine; Dopamine; Female; Growth Hormone; Heart Failure; Humans; Hydrocortisone; Male; Middle Aged; Prolactin; Time Factors; Vasodilator Agents | 1986 |
Acute haemodynamic effects of ibopamine in patients with severe congestive heart failure.
Topics: Adult; Aged; Cardiac Catheterization; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Circulation; Stroke Volume; Vascular Resistance | 1985 |
Hemodynamic advantage of combined administration of oral ibopamine and nitroprusside in patients with ischemic and idiopathic congestive cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Deoxyepinephrine; Dopamine; Drug Therapy, Combination; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitroprusside | 1985 |
[Hemodynamic effects induced by the combined administration of sodium nitroprusside and ibopamine in patients with congestive heart decompensation].
Topics: Adult; Aged; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Drug Therapy, Combination; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Male; Nitroprusside | 1985 |